Literature DB >> 26260144

Bone: Sequential osteoporosis treatment--the order of things.

Bo Abrahamsen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26260144     DOI： 10.1038/nrendo.2015.134

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  8 in total

1.  Placebo-controlled trials in osteoporosis--proceeding with caution.

Authors:  Clifford J Rosen; Sundeep Khosla
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

2.  Cortical bone: a challenging geography.

Authors:  Roger Zebaze; Ego Seeman
Journal:  J Bone Miner Res       Date:  2015-01       Impact factor: 6.741

3.  Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.

Authors:  Felicia Cosman; Erik Fink Eriksen; Chris Recknor; Paul D Miller; Núria Guañabens; Christian Kasperk; Philemon Papanastasiou; Aimee Readie; Hanumantha Rao; Jürg A Gasser; Christina Bucci-Rechtweg; Steven Boonen
Journal:  J Bone Miner Res       Date:  2011-03       Impact factor: 6.741

4.  Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.

Authors:  Benjamin Z Leder; Joy N Tsai; Alexander V Uihlein; Paul M Wallace; Hang Lee; Robert M Neer; Sherri-Ann M Burnett-Bowie
Journal:  Lancet       Date:  2015-07-02       Impact factor: 79.321

5.  Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT Study.

Authors:  Joy N Tsai; Alexander V Uihlein; Sherri-Ann M Burnett-Bowie; Robert M Neer; Yuli Zhu; Nicholas Derrico; Hang Lee; Mary L Bouxsein; Benjamin Z Leder
Journal:  J Bone Miner Res       Date:  2015-01       Impact factor: 6.741

6.  Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment.

Authors:  Barbara M Obermayer-Pietsch; Fernando Marin; Eugene V McCloskey; Peyman Hadji; Jordi Farrerons; Steven Boonen; Maurice Audran; Clare Barker; Athanasios D Anastasilakis; William D Fraser; Thomas Nickelsen
Journal:  J Bone Miner Res       Date:  2008-10       Impact factor: 6.741

Review 7.  Effects of treatment with fluoride on bone mineral density and fracture risk--a meta-analysis.

Authors:  P Vestergaard; N R Jorgensen; P Schwarz; L Mosekilde
Journal:  Osteoporos Int       Date:  2007-08-15       Impact factor: 4.507

8.  Life Expectancy in Patients Treated for Osteoporosis: Observational Cohort Study Using National Danish Prescription Data.

Authors:  Bo Abrahamsen; Clive Osmond; Cyrus Cooper
Journal:  J Bone Miner Res       Date:  2015-05-21       Impact factor: 6.741
  8 in total
  1 in total

1.  Cost-Effectiveness of Sequential Teriparatide/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China.

Authors:  Ruxu You; Jinyu Liu; Lei Ke; Guangyi Yu; Yu Zhang; Takahiro Mori
Journal:  Front Public Health       Date:  2022-02-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.